-
-
-
-
-
-
-
Mirum Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Mirum Pharmaceuticals reports preliminary 2025 sales of $520 million
-
-
-
-
-
-
-
Mirum Pharmaceuticals (MIRM) PT Raised to $100 at Leerink Partners
-
-
-
-
-
-
-
Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences
-
-
-
-
-
-
-
Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences
-
-
-
-
-
-
-
Mirum Pharmaceuticals to Present at the 2023 Evercore ISI HealthCONx Conference
-
-
-
-
-
-
-
Travere Therapeutics (TVTX) to Sell its Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases to Mirum (MIRM)
-
1,154,873 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

